Expertise in
26
conditions

Dr. Matei P. Socoteanu

Oncology
Longview Cancer Center Mobile Pet
1300 N 4th St, 
Longview, TX 
Accepting New Patients
Offers Telehealth
Expertise in
26
conditions
Longview Cancer Center Mobile Pet
1300 N 4th St, 
Longview, TX 

Overview

Matei Socoteanu is an Oncologist practicing medicine in Longview, Texas.

Dr. Socoteanu is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Lung Cancer, and Paget Disease of the Breast.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 4 clinical trials. Dr. Socoteanu is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in TN

Hospital Affiliations

Christus Good Shepherd Medical Center
Longview Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EMI Health
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Provider Partners Health Plan
  • MEDICARE SNP
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Longview Cancer Center Mobile Pet
1300 N 4th St, Longview, TX 75601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
Enrollment Status: Completed
Publish Date: June 11, 2024
Intervention Type: Drug
Study Drugs: Brentuximab, Bendamustine, Dacarbazine, Nivolumab
Study Phase: Phase 2
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
Enrollment Status: Terminated
Publish Date: January 20, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
Enrollment Status: Terminated
Publish Date: September 11, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

2 Total Publications

Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2).
Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 10, 2020
Similar Doctors
Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Longview Cancer Center Mobile Pet

1300 N 4th St, 
Longview, TX 
 (0.1 miles away)
972-997-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rama Koya is an Oncologist practicing medicine in Longview, Texas. Dr. Koya is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, and Pleuropulmonary Blastoma. Dr. Koya is currently accepting new patients.

Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required

Texas Oncology Pharmacy-Longview

1400 N 4th St, 
Longview, TX 
 (0.1 miles away)
903-757-2122
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kavita Nirmal is an Oncologist practicing medicine in Longview, Texas. Dr. Nirmal is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma. Dr. Nirmal is currently accepting new patients.

Expertise in
18
conditions
Dr. Lijo John
Oncology
Expertise in
18
conditions
Dr. Lijo John
Oncology
Referral may be required

Longview Cancer Center Mobile Pet

1300 N 4th St, 
Longview, TX 
 (0.1 miles away)
903-757-2122
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lijo John is an Oncologist practicing medicine in Longview, Texas. Dr. John is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Colorectal Cancer. Dr. John is currently accepting new patients.

Frequently Asked Questions about Dr. Matei P. Socoteanu

How do I make an appointment with Dr. Matei P. Socoteanu?

You can book an appointment with Dr. Matei P. Socoteanu by calling their office at 903-757-2122. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Matei P. Socoteanu a top-rated expert for Familial Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matei P. Socoteanu is classified as an Distinguished expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Matei P. Socoteanu specialize in?

While Dr. Matei P. Socoteanu is a Oncology, they have specific expertise in Familial Colorectal Cancer, Colorectal Cancer, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Matei P. Socoteanu participate in research or clinical trials?

Yes. Dr. Matei P. Socoteanu has published 2 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Dr. Matei P. Socoteanu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Matei P. Socoteanu accept my insurance?

Dr. Matei P. Socoteanu accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 903-757-2122 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Socoteanu's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 18 Advanced Conditions
    View All 66 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile